Geron Corporation
GERNNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for GERN. That does not mean none is planned.
Get an email about GERN's next catalysts
Track Geron (GERN) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
GERN Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.01 | FQ end Sep/2026 | Call: bmo
Market Overview
Stock performance and key metrics
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Website| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Imetelstat | Phase 3 | Myelofibrosis | - | - |
Imetelstat sodium | Phase 3 | Locally Recurrent or Metastatic Breast Cancer | - | - |
Myelofibrosis
2 drugs in this indication
Multiple Myeloma
1 drug in this indication
Locally Recurrent or Metastatic Breast Cancer
1 drug in this indication
Non-small Cell Lung Cancer
1 drug in this indication
Myelodysplastic Syndromes
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in Geron Corporation's drug pipeline?→
CatalystAlert tracks 2 drug candidates in Geron Corporation's (GERN) pipeline across Phase 3. Its lead program is Imetelstat (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Geron Corporation's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Geron Corporation (GERN) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GERN biotech catalysts?→
Add GERN to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Geron Corporation's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.